HEALIXA (EMOR) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 78 127 sessions, October 7, 2025 to October 8, 2026
- Largest daily move
- +117% close of February 12, 2026
- 1-year change
- +288.9% closing prices, October 7, 2025 to October 8, 2026
- 1-month change
- +6.1% closing prices, September 8, 2026 to October 8, 2026
Company Description
HEALIXA (OTC: EMOR) is classified in the health information services industry within the Healthcare sector and carries a market capitalization of $7.7M.
EMOR has gained 288.9% over the past year. The last closing price was $0.0350.
This page collects what Stock Titan holds for EMOR, including price data, latest news, and short interest trends.
Stock Performance
HEALIXA (EMOR) closed at $0.0350 on October 8, 2026. Over the past 12 months, the price has gained 288.9%.
EMOR Metrics & Rankings
Price returns through October 8, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
HEALIXA has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 6 with negative movement. Key topics include management. View all EMOR news →
SEC Filings
Short Interest History
Short interest in HEALIXA (EMOR) currently stands at 50 shares. Since October 2025, short interest has decreased by 99.6%.
Days to Cover History
Days to cover for HEALIXA (EMOR) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 3.1 days.
EMOR Company Profile & Sector Positioning
HEALIXA (EMOR) operates in the Health Information Services industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing EMOR often look at related companies in the same sector, including DIAGNAMED HLDGS CORP (DGNMF), COMPREHENSIVE HEALTHCARE (CMHSF), AI / ML INNOVATIONS INC (AIMLF), COMPUMED INC (CMPD), and CAREVIEW COMMUNS INC (CRVW). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EMOR's relative position within its industry.